- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
c-Src Antibody / Proto-Oncogene c-Src Polyclonal Antibody targets SRC, a non-receptor tyrosine kinase and founding member of the Src family of protein kinases. Commonly called cellular Src or c-Src, this proto-oncogene product regulates signaling pathways involved in cell proliferation, adhesion, migration, differentiation, and survival. SRC functions downstream of receptor tyrosine kinases, integrins, and G protein-coupled receptors, transmitting extracellular signals through phosphorylation of intracellular proteins. Its activity influences cytoskeletal organization, cell polarity, and communication between cells and their surrounding extracellular matrix.
The SRC protein contains an N-terminal membrane-targeting region, SH3 and SH2 interaction domains, a catalytic SH1 kinase domain, and a C-terminal regulatory tail. Myristoylation promotes membrane association, positioning SRC near receptors and signaling complexes. Its kinase activity is controlled by phosphorylation and intramolecular interactions. Phosphorylation of the C-terminal inhibitory tyrosine by C-terminal Src kinase (CSK) stabilizes an inactive conformation. Dephosphorylation and changes in SH2 and SH3 domain interactions facilitate activation, while autophosphorylation within the activation loop further enhances catalytic activity. These mechanisms allow SRC to respond rapidly to changes in growth factor signaling and cellular adhesion.
Activated SRC interacts with focal adhesion kinase (FAK), paxillin, and other proteins that regulate focal adhesion turnover and actin cytoskeletal remodeling. Through these interactions, SRC coordinates cell spreading, migration, and responses to mechanical signals. SRC also contributes to the RAS-MAPK, PI3K-AKT, and STAT pathways, connecting receptor activation to transcriptional regulation, metabolism, and cell survival. Its extensive network of substrates enables SRC to integrate growth factor signaling with adhesion-dependent processes and participate in normal tissue development and remodeling.
Dysregulated SRC signaling has been implicated in cancer progression, particularly through its effects on proliferation, invasion, migration, and resistance to apoptosis. Increased SRC activity has been investigated in colorectal, breast, lung, and other malignancies, where it can cooperate with growth factor receptors and oncogenic signaling pathways. SRC also contributes to normal cellular responses to environmental changes, making its regulation important beyond cancer biology. c-Src Antibody supports research into SRC expression, tyrosine kinase signaling, and the molecular mechanisms connecting cellular adhesion with malignant progression.
For additional validation of SRC expression across human and rodent samples, including knockout-controlled Western blot analysis, see our Src Antibody III-19.
Titration of the c-Src Antibody / Proto-Oncogene c-Src Polyclonal Antibody may be required due to differences in protocols and secondary/substrate sensitivity.
A portion of amino acids 1-30 from the human protein was used as the immunogen for this c-Src antibody.
Aliquot the c-Src antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
SRC antibody, Src antibody, Cellular Src antibody, Proto-oncogene c-Src antibody, Proto-oncogene tyrosine-protein kinase Src antibody, Tyrosine-protein kinase Src antibody, Src family kinase antibody, Src family tyrosine kinase antibody, SRC proto-oncogene antibody, p60c-Src antibody, pp60c-Src antibody, c-Src kinase antibody, Src signaling protein antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.